Success Metrics

Clinical Success Rate

81.8%

Based on 9 completed trials

Completion Rate

82%(9/11)

Active Trials

0(0%)

Results Posted

100%(9 trials)

Terminated

2(17%)

Phase Distribution

Ph phase_3

Ph phase_1

25%

Ph phase_2

42%

Ph not_applicable

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

3(27.3%)

Phase 2Efficacy & side effects

5(45.5%)

Phase 3Large-scale testing

1(9.1%)

Phase 4Post-market surveillance

1(9.1%)

N/ANon-phased studies

1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(9)

Terminated(2)

Other(1)

Detailed Status

Completed9

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

81.8%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (27.3%)

Phase 25 (45.5%)

Phase 31 (9.1%)

Phase 41 (9.1%)

N/A1 (9.1%)

Trials by Status

completed975%

terminated217%

unknown18%

Recent Activity

0 active trials

Showing 5 of 12

completed

Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.

NCT06078579

completedphase_2

Clinical Trials (12)

Showing 12 of 12 trials

NCT06078579

Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.

Completed

NCT00896298Phase 2

Trial of Leptin Replacement Therapy in Patients With Lipodystrophy

Completed

NCT00265980Not Applicable

Leptin in Human Energy and Neuroendocrine Homeostasis

Terminated

NCT01268644Phase 1

Effects of Metreleptin in Type 1 Diabetes Mellitus

Terminated

NCT00461552Phase 2

Therapeutic Approaches to HAART-Induced Lipodystrophy

Completed

NCT01275053Phase 1

In Vivo Leptin Signaling in Humans After Acute Leptin Administration

Completed

NCT01155180Phase 2

Leptin in the Maintenance of Reduced Body Weight

Completed

NCT00362440Phase 2

Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome

Completed

NCT00710814Phase 1

Trial of Leptin Administration After Roux-en-Y Gastric Bypass

Completed

NCT00073242Phase 3

Low-Dose Leptin and the Formerly-Obese

Unknown

NCT00050791Phase 2

Effects of Leptin Treatment on Weight Loss

Completed

NCT00121433Phase 4

Leptin and Endothelial Function

Completed

All 12 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 12